Launched by the Alzheimer’s Drug Discovery Foundation (ADDF) in partnership with major philanthropists and organizations, this program is on a mission to revolutionize how we diagnose and monitor Alzheimer’s and other dementias.

Have you ever heard the saying, "the eyes are the window to the soul"? In medicine, a more accurate phrase might be, "the eyes are a window to your health." A new and exciting field called ocular phenotyping is proving just how true that is, offering a non-invasive way to spot signs of diseases throughout the body, from Alzheimer's to diabetes.

The Asia Pacific (APAC) region is experiencing a healthcare revolution, driven by the rapid adoption of digital technologies.

Precision medicine requires a much broader and deeper view of a patient than traditional medicine.